Matthew Schrag, Ph.D.

Affiliations: 
2011 Biochemistry Loma Linda University, Loma Linda, United States 
Google:
"Matthew Schrag"
Mean distance: 21.09 (cluster 32)
 

Parents

Sign in to add mentor
Wolff  M. Kirsch grad student 2011 Loma Linda University
 (Cerebral Amyloid Angiopathy and Transition Metals in Alzheimer's Disease.)
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Schindler EA, Guo XM, Schrag M, et al. (2016) Neuropsychiatric Presentation of Wilson Disease in an Adolescent Male. Neuropediatrics
Schrag M, Youn T, Schindler J, et al. (2015) Intravenous Fibrinolytic Therapy in Central Retinal Artery Occlusion: A Patient-Level Meta-analysis. Jama Neurology. 72: 1148-54
Gowrishankar S, Yuan P, Wu Y, et al. (2015) Massive accumulation of luminal protease-deficient axonal lysosomes at Alzheimer's disease amyloid plaques. Proceedings of the National Academy of Sciences of the United States of America
Schrag M, Greer DM. (2014) Clinical associations of cerebral microbleeds on magnetic resonance neuroimaging. Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association. 23: 2489-97
Schrag M, Mueller C, Zabel M, et al. (2013) Oxidative stress in blood in Alzheimer's disease and mild cognitive impairment: a meta-analysis. Neurobiology of Disease. 59: 100-10
Zabel M, Schrag M, Crofton A, et al. (2013) A shift in microglial β-amyloid binding in Alzheimer's disease is associated with cerebral amyloid angiopathy. Brain Pathology (Zurich, Switzerland). 23: 390-401
Zhang K, Schrag M, Crofton A, et al. (2012) Targeted proteomics for quantification of histone acetylation in Alzheimer's disease. Proteomics. 12: 1261-8
Zabel M, Schrag M, Mueller C, et al. (2012) Assessing candidate serum biomarkers for Alzheimer's disease: a longitudinal study. Journal of Alzheimer's Disease : Jad. 30: 311-21
Prasanthi JR, Schrag M, Dasari B, et al. (2012) Deferiprone reduces amyloid-β and tau phosphorylation levels but not reactive oxygen species generation in hippocampus of rabbits fed a cholesterol-enriched diet. Journal of Alzheimer's Disease : Jad. 30: 167-82
Mueller C, Schrag M, Crofton A, et al. (2012) Altered serum iron and copper homeostasis predicts cognitive decline in mild cognitive impairment. Journal of Alzheimer's Disease : Jad. 29: 341-50
See more...